NCT07157020

Brief Summary

  1. 1.Establish a reference curve for the lateral ventricular diameter of premature infants and determine the intervention threshold for hydrocephalus after hemorrhage in premature infants based on the reference curve, providing a scientific basis for optimizing clinical intervention.
  2. 2.Apply ultrasound radiomics technology to explore and formulate new standards for imaging diagnosis and treatment; By integrating metabolomics, ultrasound radiomics and clinical data, high-risk individuals for intracranial hemorrhage and their relationship with prognosis can be identified early.
  3. 3.To explore whether advancing the indication for surgical intervention of hydrocephalus in preterm infants after hemorrhage from ventricular index P97+4mm to P97 and whether repeated lumbar puncture and drainage can improve their prognosis, with the aim of clarifying the optimal timing for intervention of hydrocephalus in preterm infants after hemorrhage and optimizing the treatment methods.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Sep 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Sep 2025Dec 2026

First Submitted

Initial submission to the registry

August 26, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 5, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

September 5, 2025

Status Verified

September 1, 2025

Enrollment Period

1.3 years

First QC Date

August 26, 2025

Last Update Submit

September 3, 2025

Conditions

Keywords

Intraventricular Hemorrhage of Prematuritypreventionearly detectionclinical evaluation

Outcome Measures

Primary Outcomes (1)

  • Death or the occurrence of neurodevelopmental disorders (NDI) before the corrected gestational age of 2 years.

    NDI can be diagnosed if any of the following conditions are met. * Cerebral palsy; * Griffiths score \<85 points for the corresponding age: The assessment times are CA at 3 months, 6 months, 9 months, 12 months, 18 months, and 24 months respectively. Any assessment score lower than 85 points is considered a positive event. * Sensorineural or mixed hearing impairment and non-congenital hearing loss require hearing AIDS or cochlear implants ④ Bilateral visual impairment; * Epilepsy.

    The assessment times are CA at 3 months, 6 months, 9 months, 12 months, 18 months, and 24 months respectively.

Study Arms (2)

Low-threshold intervention group

EXPERIMENTAL

VI\>P97,but ≤ P97+4mm

Procedure: ommaya capsule implantation technique

high-threshold intervention group

EXPERIMENTAL

VI\>P97+4mm

Procedure: ommaya capsule implantation technique

Interventions

Intervention criteria: Low-threshold intervention group and high--threshold intervention group

Also known as: Lumbar puncture drainage
Low-threshold intervention grouphigh-threshold intervention group

Eligibility Criteria

AgeUp to 28 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Gestational age: 23+0 weeks to 36+6 weeks;
  • Post-hemorrhagic hydrocephalus is confirmed by cranial ultrasound or other cranial imaging examinations.
  • No cerebrospinal fluid drainage treatment was received before enrollment.

You may not qualify if:

  • Excluding secondary IVH, including but not limited to congenital malformations, vitamin K1 deficiency, abnormal coagulation function, etc.
  • Excluding hydrocephalus caused by other reasons, including but not limited to infection, congenital malformations, intracranial space-occupying lesions, etc.
  • Treatment before diagnosis of hydrocephalus after intraventricular hemorrhage or suspected presence of central nervous system infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2025

First Posted

September 5, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

September 5, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share